Literature DB >> 18938161

Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model.

Wei Li1, Shuangshuang Dai, Jianhong An, Renping Xiong, Ping Li, Xingyun Chen, Yan Zhao, Ping Liu, Hua Wang, Peifang Zhu, Jiangfan Chen, Yuanguo Zhou.   

Abstract

The inactivation of the A(2A) receptor (A(2A)R) has been shown to neuroprotect against brain injury in several animal models of neurological disorders including stroke and Parkinson's disease. However, despite marked elevation of adenosine level, the role of the A(2A) in traumatic brain injury (TBI) remains unclear. In the present study, we investigated the effects of genetic inactivation of A(2A)Rs in the acute stage. The A(2A)R knock-out (KO) mice and their wild-type (WT) littermates were subjected to cortical impact injury by a dropping weight. The control group was only craniotomized without TBI. At 24 h post-TBI, the neurological deficit scores of the KO mice were significantly lower than that of WT littermates. Consistent with the behavioral changes, the brain water contents as well as histological changes and the TUNEL-positive cells of the injured cortex of the KO mice were significantly lower than that of WT littermates. Furthermore, the glutamate level in the cerebral spinal fluid (CSF) of the KO mice was also significantly lower than that of WT littermates. In addition, we found that at 12 h post-TBI the mRNA and protein levels of TNF-alpha and IL-1beta were higher in the KO mice than that in the WT littermates. However, at 24 h post-TBI, the level of TNF-alpha and IL-1beta continually increased in the WT mice but largely declined in the KO mice. These results suggest that the genetic inactivation of A(2A)R protects against TBI, which is mainly associated with the suppression of glutamate level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938161     DOI: 10.1016/j.expneurol.2008.09.012

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  26 in total

1.  Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.

Authors:  K Xu; D G Di Luca; M Orrú; Y Xu; J-F Chen; M A Schwarzschild
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

2.  Synergistic roles for G-protein γ3 and γ7 subtypes in seizure susceptibility as revealed in double knock-out mice.

Authors:  William F Schwindinger; Uyenlinh L Mirshahi; Kelly A Baylor; Kathleen M Sheridan; Anna M Stauffer; Stephanie Usefof; Mark M Stecker; Tooraj Mirshahi; Janet D Robishaw
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

3.  Adenosine kinase determines the degree of brain injury after ischemic stroke in mice.

Authors:  Hai-Ying Shen; Theresa A Lusardi; Rebecca L Williams-Karnesky; Jing-Quan Lan; David J Poulsen; Detlev Boison
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-23       Impact factor: 6.200

4.  Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury.

Authors:  Shuang-Shuang Dai; Yuan-Guo Zhou; Wei Li; Jian-Hong An; Ping Li; Nan Yang; Xing-Yun Chen; Ren-Ping Xiong; Ping Liu; Yan Zhao; Hai-Ying Shen; Pei-Fang Zhu; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

Review 5.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

6.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 7.  Adenosine signaling and function in glial cells.

Authors:  D Boison; J-F Chen; B B Fredholm
Journal:  Cell Death Differ       Date:  2009-09-18       Impact factor: 15.828

8.  Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction.

Authors:  Ya-Lei Ning; Nan Yang; Xing Chen; Ren-Ping Xiong; Xiu-Zhu Zhang; Ping Li; Yan Zhao; Xing-Yun Chen; Ping Liu; Yan Peng; Zheng-Guo Wang; Jiang-Fan Chen; Yuan-Guo Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

Review 9.  G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.

Authors:  José L Moreno; Terrell Holloway; Javier González-Maeso
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 10.  The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease.

Authors:  Jiang-Fan Chen; Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2020-03-31       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.